Anaemia is a serious medical condition that affects millions of people worldwide. It’s characterised by a lack of healthy red blood cells to carry adequate oxygen to the body's tissues.
This condition can lead to fatigue, weakness and various health complications if left untreated. According to the World Health Organization, anaemia affects approximately 1.62 billion people globally, with iron deficiency being the most common cause.
It can be treated with various medications, including iron supplements, vitamin B12 injections and specific iron complexes such as ferric carboxymaltose (FCM).
FCM is a well-tolerated form of iron that’s available in both tablet and injectable forms, making it particularly beneficial for patients with serious conditions such as Crohn's disease or ulcerative colitis.
To ensure that patients receive the best possible care, rigorous clinical and bioanalytical studies are essential to develop and approve new medications.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.